Maximus Hep with CurQLife®


liver supportx ray dog catCurcumin has been widely acknowledged as a botanical supplement (phytochemical) with great potential to prevent and treat wide spectrum of therapeutic conditions. In addition, it has been proved to be remarkably safe in animal studies and in many clinical evaluations even at high doses (up to 12g/day).

Several benefits have been attributed to the curcumin for a variety of health disorders, including liver disorders. Curcumin possesses anti-inflammatory and anti-oxidant properties which are the molecular basis to use it in hepatic disorders.

 

SAFETY STUDIES with CURQLIFE

Acute oral toxicity study, Dose range finding study, Primary eye irritation study, Primary dermal irritation study, Bacterial reverse mutation test & In vivo erythrocyte micronucleus test.

 

EFFICACY STUDIES WITH CURQLIFE:

TNF α, IL-1 β, IL-6 and MMP-3 inhibition studies, CaCo-2 cell uptake studies, Carrageenan Induced Anti-inflammatory study, Animal Bioavailability study & Human bioavailability study.

 

curqlife softgelProduct features and key characteristics

  • Unique delivery system resulting in improved pharmacokinetics and pharmacodynamic profile
  • The new unique formulation promotes quick penetration into the cells
  • Possess enhanced bioavailability
  • Imparts significantly better efficacy
  • The novel formulation provides protection of the bioactive ingredient, curcuminoids from biological degradation
  • Unique mechanism of action
  • Quick onset of action.

Supporting clinical study on Curcumin ingredient against Hepatoxicity

Curcumin against hepatic toxicity
Curcumin as a Potent and Selective Inhibitor of 11b-Hydroxysteroid Dehydrogenase 1: Improving LipidProfiles in High-Fat-Diet-Treated Rats
Curcumin attenuates angiogenesis in liver fibrosis andinhibits angiogenic properties of hepatic stellate cells
Curcumin Prevents Bile Canalicular Alterations in the Liver of Hamsters Infected with Opisthorchis viverrini
Curcumin Protects against CCl4-Induced Liver Fibrosis in Rats by Inhibiting HIF-1α Through an ERK-Dependent Pathway
Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis
Potential Therapeutic Efficacy of Curcumin in Liver Cancer


©2018 PETdiatric Laboratories. All Rights Reserved.